- Home
- ZBH vs ASND Comparison
ZBH vs ASND Comparison
Compare ZBH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZBH | ASND |
|---|---|---|
| Founded | 1927 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 15.0B |
| IPO Year | 2001 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ZBH | ASND |
|---|---|---|
| Price | $95.01 | $224.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 21 |
| Target Price | $106.82 | ★ $306.03 |
| AVG Volume (30 Days) | ★ 1.8M | 757.5K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $8,231,500,000.00 | N/A |
| Revenue This Year | $4.43 | $90.81 |
| Revenue Next Year | $3.54 | $46.89 |
| P/E Ratio | $41.98 | ★ N/A |
| Revenue Growth | ★ 7.20 | N/A |
| 52 Week Low | $79.12 | $186.05 |
| 52 Week High | $106.88 | $282.15 |
Technical Indicators
Market Signals| Indicator | ZBH | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 57.01 | 41.29 |
| Support Level | $94.28 | $216.52 |
| Resistance Level | $98.20 | $249.89 |
| Average True Range (ATR) | 1.98 | 5.64 |
| MACD | 0.76 | 0.75 |
| Stochastic Oscillator | 87.73 | 41.75 |
Price Performance
Historical ComparisonAbout ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.